Efficacy and safety of sofosbuvir-based therapy for chronic hepatitis C infection in “real-life” cohort-Reference-Cited by-同舟云学术

Efficacy and safety of sofosbuvir-based therapy for chronic hepatitis C infection in “real-life” cohort

Published:2016-11 Issue:6 Volume:35 Page:459-464
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Mehta Rajiv,Kabrawala Mayank,Nandwani Subhash,Tekriwal Rini,Nandaniya Payal,Shah Mrunal,Bhayani Vishwa

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s12664-016-0713-5.pdf

Reference21 articles.

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–42.

2. Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva: World Health Organization 2016.

3. Cornberg M, Deterding K, Manns MP. Present and future therapy for hepatitis C virus. Expert Rev Anti Infect Ther. 2006;4:781–93.

4. Mangia A, Piazzolla V. Overall efficacy and safety results of sofosbuvir-based therapies in phase II and III studies. Dig Liver Dis. 2014;46 Suppl 5 :S179–85.

5. Pol S, Sulkowski MS, Hassanein T, et al. Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed. Hepatology. 2015;62:129–34.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C;Interdisciplinary Perspectives on Infectious Diseases;2018-10-01

2. Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia;BMJ Open Gastroenterology;2018-08

3. Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major;Journal of Clinical and Experimental Hepatology;2018-03

4. Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?;Journal of Clinical and Experimental Hepatology;2017-09

5. Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT);Journal of Viral Hepatitis;2017-08-14